BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7943127)

  • 1. Technique for determining glaucomatous visual field progression by using animation graphics.
    Chauhan BC; Drance SM; LeBlanc RP; Lieberman MF; Mills RP; Werner EB
    Am J Ophthalmol; 1994 Oct; 118(4):485-91. PubMed ID: 7943127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Home Monitoring Allow Earlier Detection of Rapid Visual Field Progression in Glaucoma?
    Anderson AJ; Bedggood PA; George Kong YX; Martin KR; Vingrys AJ
    Ophthalmology; 2017 Dec; 124(12):1735-1742. PubMed ID: 28764889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraobserver and Interobserver Agreement of Structural and Functional Software Programs for Measuring Glaucoma Progression.
    Moreno-Montañés J; Antón V; Antón A; Larrosa JM; Martinez-de-la-Casa JM; Rebolleda G; Ussa F; García-Granero M
    JAMA Ophthalmol; 2017 Apr; 135(4):313-319. PubMed ID: 28241171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agreement in detecting glaucomatous visual field progression by using guided progression analysis ?and Humphrey overview printout.
    Iester M; Corallo G; Capris E; Capris P
    Eur J Ophthalmol; 2011; 21(5):573-9. PubMed ID: 21319135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effective Dynamic Ranges for Glaucomatous Visual Field Progression With Standard Automated Perimetry and Stimulus Sizes III and V.
    Wall M; Zamba GKD; Artes PH
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):439-445. PubMed ID: 29356822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative comparison of static perimetric strategies in early glaucoma: test-retest variability.
    Spry PG; Henson DB; Sparrow JM; North RV
    J Glaucoma; 2000 Jun; 9(3):247-53. PubMed ID: 10877376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Heidelberg retina tomograph Glaucoma Probability Score: reproducibility and measurement of progression.
    Strouthidis NG; Demirel S; Asaoka R; Cossio-Zuniga C; Garway-Heath DF
    Ophthalmology; 2010 Apr; 117(4):724-9. PubMed ID: 20045564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of glaucoma progression analysis software in a glaucoma population.
    Arnalich-Montiel F; Casas-Llera P; Muñoz-Negrete FJ; Rebolleda G
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):391-7. PubMed ID: 18982343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of Technologies for Glaucoma Case-Finding in a Community Setting.
    Dabasia PL; Fidalgo BR; Edgar DF; Garway-Heath DF; Lawrenson JG
    Ophthalmology; 2015 Dec; 122(12):2407-15. PubMed ID: 26411836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glaucomatous optic nerve atrophy: the circumlinear vessel revisited.
    Kasner O; Balazsi AG
    Can J Ophthalmol; 1991 Aug; 26(5):264-9. PubMed ID: 1933665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Retinal Nerve Fiber Layer Thickness, the Mean Deviation, and the Visual Field Index in Progressive Glaucoma.
    Banegas SA; Antón A; Morilla A; Bogado M; Ayala EM; Fernandez-Guardiola A; Moreno-Montañes J
    J Glaucoma; 2016 Mar; 25(3):e229-35. PubMed ID: 26020689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
    Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
    Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between structural abnormalities and short-wavelength perimetric defects in eyes at risk of glaucoma.
    Ugurlu S; Hoffman D; Garway-Heath DF; Caprioli J
    Am J Ophthalmol; 2000 May; 129(5):592-8. PubMed ID: 10844049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blue-on-yellow visual field and retinal nerve fiber layer in ocular hypertension and glaucoma.
    Teesalu P; Airaksinen PJ; Tuulonen A
    Ophthalmology; 1998 Nov; 105(11):2077-81. PubMed ID: 9818609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of gaze tracking during perimetry in glaucomatous eyes].
    Kunimatsu S; Suzuki Y; Shirato S; Araie M
    Nippon Ganka Gakkai Zasshi; 1999 Oct; 103(10):748-53. PubMed ID: 10554550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.
    Keltner JL; Johnson CA; Levine RA; Fan J; Cello KE; Kass MA; Gordon MO
    Arch Ophthalmol; 2005 Sep; 123(9):1201-6. PubMed ID: 16157799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blue-on-yellow perimetry using an Armaly glaucoma screening program.
    Maeda H; Tanaka Y; Nakamura M; Yamamoto M
    Ophthalmologica; 1999; 213(2):71-5. PubMed ID: 9885383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual fields and OCT role in diagnosis of glaucoma.
    Bae HW; Lee KH; Lee N; Hong S; Seong GJ; Kim CY
    Optom Vis Sci; 2014 Nov; 91(11):1312-9. PubMed ID: 25279784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of early glaucomatous progression with octopus cluster trend analysis.
    Naghizadeh F; Holló G
    J Glaucoma; 2014; 23(5):269-75. PubMed ID: 24892507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.